Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people who stop Mounjaro do regain some weight, but how much depends largely on what happens in the months before and after stopping. Keeping weight off after Mounjaro is achievable when the habits built during treatment — reduced appetite, smaller portions, more movement — are carried forward deliberately and with clinical support. These are prescription-only medicines; a GPhC-registered prescriber should be involved in any plan around changing or ending treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The groundwork for keeping weight off after Mounjaro starts well before the last pen. During treatment, tirzepatide is doing a lot of the heavy lifting on appetite signals through its dual GIP and GLP-1 receptor action. When that signal fades, hunger tends to creep back. People who use the treatment period to build genuine habits (not just to eat less because the medicine makes it easy) tend to fare significantly better afterwards.
Practically, that means locking in a reliable eating pattern before you stop: consistent meal timing, adequate protein at each meal (most adults aiming for roughly 25–30g per sitting), and enough fibre to slow gastric emptying by non-pharmacological means. This is not about following a rigid plan. It is about making the pattern automatic enough that it does not require willpower to sustain.
The Mounjaro treatment overview explains how tirzepatide works mechanically, which helps in understanding what changes when it is no longer present. Knowing the biology tends to motivate the habits better than being told to eat vegetables.
Strength training is worth mentioning here too. GLP-1 treatments reduce overall calorie intake, and without sufficient protein and resistance exercise, some of the weight lost can include muscle mass. Rebuilding or protecting that muscle before stopping is much easier than recovering it afterwards.
Can you keep weight off after Mounjaro? Yes, but not by guessing the exit. An abrupt stop at the highest dose carries a higher rebound risk than a planned, gradual reduction, and the clinical evidence broadly supports this. The NHS England guidance on weight-management injections explicitly frames these medicines as part of a wider programme rather than a standalone fix, which is the right frame for thinking about what comes next.
A prescriber can review whether stopping is actually the right call at this point, or whether a lower maintenance dose makes more sense for your clinical picture. For some people, staying on Mounjaro longer term is clinically appropriate and simply not something they had considered as an option.
If you are transferring from another service or considering a dose change, our prescribers at nume review each case individually, there are no automated decisions. You can read more about our clinical team's approach if you want to understand what that review involves. The point is: do not make the stop decision alone, and do not time it around stock availability or cost rather than clinical readiness.
For context on private treatment costs and what to look for in transparent pricing, the Mounjaro price comparison guide sets out the market clearly.
The first twelve weeks after stopping are when hunger signals typically return most noticeably. Some people describe it as a slow fade; others find it arrives quite sharply in the second or third week. Both are normal. The practical move is to anticipate it rather than be caught off-guard.
Three things help most in this window. First, keeping meal structure rigid even when appetite feels manageable, skipping meals tends to lead to larger, less controlled eating later. Second, having protein sources that are genuinely convenient: eggs in the fridge, Greek yoghurt on the shelf, nuts in the gym bag, whatever fits your actual life rather than a meal-plan ideal. Third, tracking weight weekly rather than daily. Daily fluctuations are driven mostly by fluid, and they tend to produce anxiety rather than useful information.
The evidence on weight regain after Mounjaro covers what the trials show in more detail, and it is worth reading before stopping so expectations are calibrated. Some regain is normal and does not represent failure. The question is the trajectory over months, not the number on a single morning.
The NHS's healthy weight guidance offers a solid evidence-based framework for the diet and activity side of maintenance. It is less prescriptive than some commercial programmes and tends to be more sustainable as a result.
If weight is returning steadily despite consistent effort over two to three months, that is a clinical signal, not a personal failure. Obesity is a chronic condition shaped heavily by biology, and for many people it requires ongoing clinical management rather than a one-time intervention.
A return to treatment is a legitimate, medically sound option. So is a lower maintenance dose rather than full discontinuation. The longer guide on keeping weight off after stopping Mounjaro covers the decision points in more detail. If you find yourself wondering whether a second course might work differently from the first, the evidence on repeat treatment is worth reviewing before drawing conclusions.
Our prescribers are available seven days a week for aftercare questions. If you are a current or former patient and things are not going as expected, getting in touch is the right first step rather than stopping treatment abruptly or restarting without review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.